Homocysteine levels, MTHFR C677T genotype, and MRI hyperintensities in late-onset major depressive disorder

American Journal of Geriatric Psychiatry

Volumn 13, Issue 10, 2005, Pages 869-875

  Chen, Cheng Sheng ^a,b,c,e   Tsai, Jer Chia ^a   Tsang, Hin Yeung ^d   Kuo, Yu Ting ^a   Lin, Hsiu Fen ^a   Chiang, I Chan ^a   Devanand, D P ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PRIMER DNA;

AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLIC ACID BLOOD LEVEL; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; BLOOD; BRAIN; GENE EXPRESSION; GENETICS; LEUKOCYTE; METABOLISM; MIDDLE AGED; ONSET AGE; PATHOLOGY; POLYMERASE CHAIN REACTION;

AGE OF ONSET; AGED; BRAIN; DEPRESSIVE DISORDER, MAJOR; DNA PRIMERS; FEMALE; GENE EXPRESSION; GENOTYPE; HOMOCYSTEINE; HUMANS; LEUKOCYTES; MAGNETIC RESONANCE IMAGING; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 33644873418     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/00019442-200510000-00006     Document Type: Article

References (44)

1. Finkelstein JD: The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998; 157(suppl2):S40-S44
2. Kang SS, Zhou J, Wong PW, et al: Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43:414-421
3. Kang SS, Wong PW, Susmano A, et al: Thermolabile methylene- tetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48:536-545
4. Engbersen AM, Franken DG, Boers GH, et al: Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995; 56:142-150
5. Clarke R, Daly L, Robinson K, et al: Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-1155
6. Selhub J, Jacques PF, Bostom AG, et al: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332:286-291
7. Fassbender K, Mielke O, Bertsch T, et al: Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999; 353:1586-1587
8. McCaddon A, Hudson P, Davies G, et al: Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001; 12:309-313
9. Seshadri S, Beiser A, Selhub J, et al: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-483
10. Dufouil C, Alperovitch A, Ducros V, et al: Homocysteine, white-matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003; 53:214-221
11. Religa D, Styczynska M, Peplonska B, et al: Homocysteine, apolipoprotein-E, and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2003; 16:64-70
12. 12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003; 60:618-626
13. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501
14. Fujikawa T, Yamawaki S, Touhouda Y: Incidence of silent cerebral infarction in patients with major depression. Stroke 1993; 24:1631-1634
15. Alexopoulos GS, Meyers BS, Young RC, et al: "Vascular depression" hypothesis. Arch Gen Psychiatry 1997; 54:915-922
16. Tsang HY, Chong MY, Cheng AT: Development of the Chinese version of the Geriatric Mental State Schedule. Int Psychogeriatr 2002; 14:219-226
17. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
18. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
19. Spitzer RL, Endicott J, Fleiss JL, et al: The Psychiatric Status Schedule: a technique for evaluating psychopathology and impairment in role functioning. Arch Gen Psychiatry 1970; 23:41-55
20. Wing J, Nixon J, von Cranach M, et al: Further developments of the "present state examination" and CATEGO system. Arch Psychiatr Nervenkr 1977; 224:151-160
21. Frosst P, Blom HJ, Milos R, et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-113
22. Fazekas F, Niederkorn K, Schmidt R, et al: White-matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988; 19:1285-1288
23. Taylor WD, Steffens DC, Krishnan RR: Vascular depression: a new subtype of depressive disorder?, in Vascular Disease and Affective Disorders. Edited by Chiu E, Ames D, Katona C. London, UK, Martin Dunitz, 2002, pp 149-160
24. Bottiglieri T, Laundy M, Crellin R, et al: Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69:228-232
25. Hogervorst E, Ribeiro HM, Molyneux A, et al: Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white-matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002; 59:787-793
26. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al: Homocysteine, silent brain infarcts, and white-matter lesions: The Rotterdam Scan Study. Ann Neurol 2002; 51:285-289
27. Krishnan KR, Goli V, Ellinwood EH, et al: Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry 1988; 23:519-522
28. Catoni GL: S-Adenosylmethionine; a new intermediate formed enzymatically from L-methionine and adenosinetriphosphate. J Biol Chem 1953; 204:403-416
29. Bottiglieri T, Hyland K, Reynolds EH: The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 1994; 48:137-152
30. Kim WK, Pae YS: Involvement of N-methyl-d-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett 1996; 216:117-120
31. Kruman II, Culmsee C, Chan SL, et al: Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000; 20:6920-6926
32. Green RC, Cupples LA, Kurz A, et al: Depression as a risk factor for Alzheimer disease: The MIRAGE Study. Arch Neurol 2003; 60:753-759
33. Jorm AF: Is depression a risk factor for dementia or cognitive decline? a review. Gerontology 2000; 46:219-227
34. Prins ND, Den Heijer T, Hofman A, et al: Homocysteine and cognitive function in the elderly: The Rotterdam Scan Study. Neurology 2002; 59:1375-1380
35. Wright CB, Lee HS, Paik MC, et al: Total homocysteine and cognition in a tri-ethnic cohort: The Northern Manhattan Study. Neurology 2004; 63:254-260
36. Kunugi H, Fukuda R, Hattori M, et al: C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 1998; 3:435-437
37. Arinami T, Yamada N, Yamakawa-Kobayashi K, et al: Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 1997; 74:526-528
38. Kelly PJ, Rosand J, Kistler JP, et al: Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 2002; 59:529-536
39. Klerk M, Verhoef P, Clarke R, et al: MTHFR 677C->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002; 288:2023-2031
40. Cervilla J, Prince M, Joels S, et al: Genes related to vascular disease (APOE, VLDL-R, DCP-1) and other vascular factors in late-life depression. Am J Geriatr Psychiatry 2004; 12:202-210
41. Steffens DC, Krishnan KR: Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43:705-712
42. Greenwald BS, Kramer-Ginsberg E, Krishnan RR, et al: MRI signal hyperintensities in geriatric depression. Am J Psychiatry 1996; 153:1212-1215
43. Lenze E, Cross D, McKeel D, et al: White-matter hyperintensities and gray-matter lesions in physically healthy depressed subjects. Am J Psychiatry 1999; 156:1602-1607
44. Rabins PV, Pearlson GD, Aylward E, et al: Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry 1991; 148:617-620